arrow_back Back to App

Non-Invasive Diagnostic Devices: Faster Access to Medical Innovation.

This act aims to exempt non-invasive diagnostic devices from regulation as medical devices, potentially accelerating their market availability. This means citizens could gain quicker access to new technologies for diagnosing illnesses that do not require breaching the body's integrity.
Key points
Non-invasive diagnostic devices, such as those that do not penetrate the skin or are not implanted, will be exempt from stringent regulations.
This change could shorten the time it takes for new, safe diagnostic methods to reach the market, potentially lowering costs and increasing patient access.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_71
Sponsor: Rep. Biggs, Andy [R-AZ-5]
Process start date: 2023-01-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Medical Innovation Acceleration Act of 2023

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_71.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-01-09.

What are the main provisions?

Key points include:

  • Non-invasive diagnostic devices, such as those that do not penetrate the skin or are not implanted, will be exempt from stringent regulations.
  • This change could shorten the time it takes for new, safe diagnostic methods to reach the market, potentially lowering costs and increasing patient access.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Biggs, Andy [R-AZ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-25.

CATEGORIES

Health